Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63629-2241

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 63629-2241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292241)

This is a medication description for Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide Tablets. Each tablet consists of 40mg Olmesartan Medoxomil, 6.9mg Amlodipine Besylate, and 25mg Hydrochlorothiazide. These tablets should be kept away from the reach of children and stored at 20°C to 25°C. This medication must be dispensed in a secured light-resistant container with a child-resistant closure. This medication is only available with a prescription. The National Drug Code of the medicine is 63629-2241-1, and the lot number is LL¥22629E9.*

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

This appears to be a set of numerical values, potentially related to a measurement or assessment. The values range from 55 to 98 and include a "baseline" marker. There are also some alphanumeric codes present that could represent a test or measurement type. However, without further context or a clearer image, it is not possible to determine the exact purpose or meaning behind these values.*

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

This is a chart or graph depicting the mean ambulatory systolic blood pressure at endpoint by treatment and hours post-dose. The treatments mentioned are Baeine, AML10/HeTZ25, OM40/AML10/HCTZ25, and ONA0/ACTZ25. The x-axis shows the hours post-dose, while the y-axis shows the systolic blood pressure in mmHg.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.